Cargando…
Reprogramming Tumor-Immune Cell Interface in Solid and Hematological Malignancies to Enhance Response to Therapy
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838855/ https://www.ncbi.nlm.nih.gov/pubmed/29506548 http://dx.doi.org/10.1186/s13046-018-0710-x |
| _version_ | 1783304316230041600 |
|---|---|
| author | Di Martino, Maria Teresa Zazzeroni, Francesca Donadelli, Massimo Chiodoni, Claudia Caraglia, Michele Scotlandi, Katia Meschini, Stefania Leonetti, Carlo |
| author_facet | Di Martino, Maria Teresa Zazzeroni, Francesca Donadelli, Massimo Chiodoni, Claudia Caraglia, Michele Scotlandi, Katia Meschini, Stefania Leonetti, Carlo |
| author_sort | Di Martino, Maria Teresa |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5838855 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-58388552018-03-09 Reprogramming Tumor-Immune Cell Interface in Solid and Hematological Malignancies to Enhance Response to Therapy Di Martino, Maria Teresa Zazzeroni, Francesca Donadelli, Massimo Chiodoni, Claudia Caraglia, Michele Scotlandi, Katia Meschini, Stefania Leonetti, Carlo J Exp Clin Cancer Res Meeting Report BioMed Central 2018-03-05 /pmc/articles/PMC5838855/ /pubmed/29506548 http://dx.doi.org/10.1186/s13046-018-0710-x Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Meeting Report Di Martino, Maria Teresa Zazzeroni, Francesca Donadelli, Massimo Chiodoni, Claudia Caraglia, Michele Scotlandi, Katia Meschini, Stefania Leonetti, Carlo Reprogramming Tumor-Immune Cell Interface in Solid and Hematological Malignancies to Enhance Response to Therapy |
| title | Reprogramming Tumor-Immune Cell Interface in Solid and Hematological Malignancies to Enhance Response to Therapy |
| title_full | Reprogramming Tumor-Immune Cell Interface in Solid and Hematological Malignancies to Enhance Response to Therapy |
| title_fullStr | Reprogramming Tumor-Immune Cell Interface in Solid and Hematological Malignancies to Enhance Response to Therapy |
| title_full_unstemmed | Reprogramming Tumor-Immune Cell Interface in Solid and Hematological Malignancies to Enhance Response to Therapy |
| title_short | Reprogramming Tumor-Immune Cell Interface in Solid and Hematological Malignancies to Enhance Response to Therapy |
| title_sort | reprogramming tumor-immune cell interface in solid and hematological malignancies to enhance response to therapy |
| topic | Meeting Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838855/ https://www.ncbi.nlm.nih.gov/pubmed/29506548 http://dx.doi.org/10.1186/s13046-018-0710-x |
| work_keys_str_mv | AT dimartinomariateresa reprogrammingtumorimmunecellinterfaceinsolidandhematologicalmalignanciestoenhanceresponsetotherapy AT zazzeronifrancesca reprogrammingtumorimmunecellinterfaceinsolidandhematologicalmalignanciestoenhanceresponsetotherapy AT donadellimassimo reprogrammingtumorimmunecellinterfaceinsolidandhematologicalmalignanciestoenhanceresponsetotherapy AT chiodoniclaudia reprogrammingtumorimmunecellinterfaceinsolidandhematologicalmalignanciestoenhanceresponsetotherapy AT caragliamichele reprogrammingtumorimmunecellinterfaceinsolidandhematologicalmalignanciestoenhanceresponsetotherapy AT scotlandikatia reprogrammingtumorimmunecellinterfaceinsolidandhematologicalmalignanciestoenhanceresponsetotherapy AT meschinistefania reprogrammingtumorimmunecellinterfaceinsolidandhematologicalmalignanciestoenhanceresponsetotherapy AT leonetticarlo reprogrammingtumorimmunecellinterfaceinsolidandhematologicalmalignanciestoenhanceresponsetotherapy |